Rebekah James

Rebekah James is a Researcher at the University of Western Australia's UWA Medical School, specializing in retinal diseases, epigenetics, and neuroprotection. Her work contributes to UN Sustainable Development Goals including health and well-being for all ages and quality education in biomedical sciences.

• Research Focus: Treatment development for retinal disorders using 661W cell line and probucol-based drug delivery strategies.
• Key Disciplines: Neuroscience, Pharmacology, Biopharmaceutics, and Epigenetics.

Recent publications highlight her role in advancing antioxidant therapies targeting oxidative stress in retinal degeneration and analyzing epigenetic modifications in inherited retinal diseases. Collaborations span institutions like European Journal of Pharmaceutics and Biopharmaceutics, with open-access contributions. Her citation metrics include an h-index of 5 and 100+ citations, emphasizing impact in retinal disease research.